Genomma Lab Internacional Stock Number Of Employees
Genomma Lab Internacional fundamentals help investors to digest information that contributes to Genomma Lab's financial success or failures. It also enables traders to predict the movement of Genomma Pink Sheet. The fundamental analysis module provides a way to measure Genomma Lab's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Genomma Lab pink sheet.
Genomma |
Genomma Lab Internacional Company Number Of Employees Analysis
Genomma Lab's Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Current Genomma Lab Number Of Employees | 2.3 K |
Most of Genomma Lab's fundamental indicators, such as Number Of Employees, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Genomma Lab Internacional is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
CompetitionBased on the recorded statements, Genomma Lab Internacional is currently employing 2.3 K people. This is 79.11% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The number of employees for all United States stocks is 87.81% higher than that of the company.
Genomma Number Of Employees Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Genomma Lab's direct or indirect competition against its Number Of Employees to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Genomma Lab could also be used in its relative valuation, which is a method of valuing Genomma Lab by comparing valuation metrics of similar companies.Genomma Lab is currently under evaluation in number of employees category among its peers.
Genomma Fundamentals
Return On Equity | 0.13 | |||
Return On Asset | 0.0921 | |||
Profit Margin | 0.08 % | |||
Operating Margin | 0.20 % | |||
Current Valuation | 1.09 B | |||
Shares Outstanding | 1 B | |||
Shares Owned By Insiders | 29.00 % | |||
Shares Owned By Institutions | 29.10 % | |||
Price To Earning | 11.09 X | |||
Price To Book | 1.38 X | |||
Price To Sales | 0.05 X | |||
Revenue | 15.49 B | |||
Gross Profit | 9.56 B | |||
EBITDA | 2.84 B | |||
Net Income | 1.31 B | |||
Cash And Equivalents | 1.3 B | |||
Cash Per Share | 1.30 X | |||
Total Debt | 3.83 B | |||
Debt To Equity | 0.51 % | |||
Current Ratio | 1.67 X | |||
Book Value Per Share | 10.98 X | |||
Cash Flow From Operations | 1.47 B | |||
Earnings Per Share | 0.07 X | |||
Number Of Employees | 2.3 K | |||
Beta | 0.53 | |||
Market Capitalization | 973.77 M | |||
Total Asset | 21.54 B | |||
Annual Yield | 0.05 % | |||
Net Asset | 21.54 B | |||
Last Dividend Paid | 0.38 |
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Consideration for investing in Genomma Pink Sheet
If you are still planning to invest in Genomma Lab Internacional check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Genomma Lab's history and understand the potential risks before investing.
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |